SLB
46
-3
IPG
50
-2
FLR
55
-4
ROK
52
-2
NEE
54
-3
SE
54
-4
PSX
27
-7
SYK
46
4
BF.B
39
-4
KLAC
45
3
PNW
66
-3
PLD
50
-5
EMN
48
-4
FCX
63
-2
EL
45
2
CCI
38
-3
BBY
38
-2
VNO
65
-3
HST
70
17
OI
38
-4
SLB
46
-3
IPG
50
-2
FLR
55
-4
ROK
52
-2
NEE
54
-3
SE
54
-4
PSX
27
-7
SYK
46
4
BF.B
39
-4
KLAC
45
3
PNW
66
-3
PLD
50
-5
EMN
48
-4
FCX
63
-2
EL
45
2
CCI
38
-3
BBY
38
-2
VNO
65
-3
HST
70
17
OI
38
-4
Financhill
Back

Pliant Therapeutics 10K Form

Buy
60

PLRX
Pliant Therapeutics

Last Price:
14.64
Seasonality Move:
0.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PLRX News And Ratings

See the #1 stock for the next 7 days that we like better than PLRX

PLRX Financial Statistics

Sales & Book Value

Annual Sales: $1.58M
Cash Flow: $-46.55M
Price / Cash Flow: 0
Annual Sales: $6.50
Price / Book: 2.28

Profitability

EPS (TTM): -3.09000
Net Income (TTM): $-185.41M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Pliant Therapeutics Earnings Forecast

Key Pliant Therapeutics Financial Ratios

  • The Research & Development expenses have been 8,088.42% of Revenue.
  • The Interest Expense is -0.79% of Operating Income.
  • The Net Earning history of PLRX is -10,211.14% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Pliant Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: PLRX
CUSIP: 729139
Website: pliantrx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PLRX Technical Analysis vs Fundamental Analysis

Buy
60
Pliant Therapeutics (PLRX) is a Buy

Is Pliant Therapeutics a Buy or a Sell?